Havens Advisors’s ChemoCentryx CCXI Stock Holding History
Bought
Maintained
Sold
Other funds holding CCXI
Havens Advisors's CCXI Position: Q4 2022 in Review
Havens Advisors sold out of ChemoCentryx (CCXI) in Q4 2022, closing a stake of 75,000 shares — an estimated $3.88M sold.
Havens Advisors first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $3.88M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Havens Advisors reported no remaining ChemoCentryx position as of Q4 2022 after selling out during the quarter.
- Havens Advisors sold 75,000 ChemoCentryx shares in Q4 2022, an estimated $3.88M.
- Havens Advisors first reported a position in ChemoCentryx in Q3 2022 and held it in 1 quarter.
- Havens Advisors's ChemoCentryx position peaked at $3.88M in Q3 2022.
- 1 fund tracked by Wall St. Rank held ChemoCentryx as of Q4 2022.
Based on Havens Advisors's 13F filing for Q4 2022, filed 25 Jan 2023.